Pharmaceuticals

Showing 1-10 of 18

19 Sep 2018  |  North America

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...

USD 4,950.00

USD 4,455.00 save 10 %

24 Apr 2018  |  North America

Growth Insights—Real World Evidence Analytics Solutions Market

Innovation and Changing End-user Needs Driving Market Growth

Over the last 3-5 years, growing cost pressure on healthcare and pharmaceutical companies and a significant shift towards outcome based healthcare approach have resulted in companies increasingly adopting real world data and evidence solutions to optimize their operation and cost using analytics. Earlier, applications of RWE were largely limited to...

USD 3,000.00

USD 2,700.00 save 10 %

12 Apr 2018  |  Europe

Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action

Establishment of Need-based Business Models with Advancements in Manufacturing Techniques is Driving Market Growth

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

USD 3,000.00

USD 2,550.00 save 15 %

20 Nov 2017  |  North America

Global Biologics Market—Companies-to-Action

Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

USD 3,000.00

USD 2,550.00 save 15 %

27 Sep 2017  |  Africa

East African Pharmaceutical Market, Forecast to 2021

Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers

Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities ...

USD 4,950.00

USD 3,712.50 save 25 %

19 Apr 2017  |  Asia Pacific

Global CRO Market, Forecast to 2021

The Global CRO Market to Reach $64.58 Billion by 2021

The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...

USD 4,950.00

USD 3,712.50 save 25 %

02 Mar 2017  |  Global

Biomarkers Enabling Diabetes and Obesity Management

Novel Biomarker Research is Likely to Transform the Future of Obesity and Diabetes Management

Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management ...

USD 4,950.00

USD 3,712.50 save 25 %

16 Aug 2016  |  North America

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Emerging Business Models Drive Transformation

The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to c...

USD 7,000.00

USD 5,250.00 save 25 %

31 May 2016  |  Asia Pacific

2016 Indonesia Transformational Health Insights

Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage

Indonesia is expected to see a substantial rise in healthcare spending driven by rapid urbanization, a growing middle class population, and an increasing prevalence of chronic diseases. Government initiatives to provide universal healthcare coverage (UHC) by 2019 are one of the key reasons for making Indonesia an attractive healthcare market. All t...

USD 1,500.00

USD 1,125.00 save 25 %

27 May 2016  |  Africa

Pharmaceutical Market Access Strategy for Ethiopia

Landscaping New Investment Opportunities Across the Pharmaceutical Value Chain

Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...

USD 4,950.00

USD 3,712.50 save 25 %

Showing 1-10 of 18